In addition, cfDNA methylation model as opposed to CEA and CA19‐9 monitoring, correlated well with AA and tumor stage (Table 2), showcasing the advantage of the cfDNA methylation model over CEA and CA19‐9 in the early detection of CRC. This evidence concerns the gene CEACAM5 and colorectal carcinoma.